Quinolone

Consumption of antimicrobials in animals reaches lowest level ever in Europe

Retrieved on: 
星期一, 十二月 18, 2023
Sale, Antimicrobial, Aquaculture, Risk, Collection, Goal, Quinolone, EMA, Animal, Annual report, Polymyxin, Bacteria, Antimicrobial spectrum, International Television Expert Group, Legislation, Public, Vaccine, European

Overall sales of veterinary antibiotics decreased by 53% between 2011 and 2022, reaching the lowest level ever reported, according to data from 25 countries.

Key Points: 
  • Overall sales of veterinary antibiotics decreased by 53% between 2011 and 2022, reaching the lowest level ever reported, according to data from 25 countries.
  • This is one of the key findings of the thirteenth annual report on the European Surveillance of Veterinary Antimicrobial Consumption (ESVAC): 2009 - 2023.
  • EMA has been monitoring sales of veterinary antimicrobials in Europe through the ESVAC project since 2009, when 9 European countries volunteered to provide data on sales of veterinary antimicrobials.
  • ESVAC has led to the collection of reliable data on antimicrobials sold for use in animals, providing invaluable insights for participating countries on the impact of their measures to promote the prudent use and setting targets to reduce the consumption of antimicrobials in animals.

Worldwide Legionella Testing Industry to 2027 - Featuring Abbott Laboratories, BioMerieux and Takara Bio Among Others - ResearchAndMarkets.com

Retrieved on: 
星期五, 六月 17, 2022
Health, Biotechnology, Macrolide, Industry, Infection, Tetracycline, Mortality, Doxycycline, COVID-19, Water, Culture, Trimethoprim, Pneumonia, Sputum, Quinolone, Pontiac, Community-acquired pneumonia, Cancer, Antigen, Person-centered therapy, Growth, DFA, Urine, WSP, Kidney disease, Bacteria, HIV, Legislation, Adult, Patient, Polymerase chain reaction, Minocycline, Hospital, PCR, Blood, Pontiac fever, Smoke, Diabetes, Risk, Vaccine, Potash, Legionella

Legionella is an infection affecting the lower respiratory tract, which can lead to severe pneumonia, Pontiac fever, and illness with flu-like symptoms.

Key Points: 
  • Legionella is an infection affecting the lower respiratory tract, which can lead to severe pneumonia, Pontiac fever, and illness with flu-like symptoms.
  • Its testing helps to identify the existence of bacteria or antigens in blood, urine, and sputum.
  • As per the testing results, macrolides, quinolones, tetracycline, doxycycline, minocycline, trimethoprim and other antibiotic treatments are usually administered to patients.
  • What is the structure of the global legionella testing industry and who are the key players?

Global Urinary Tract Infection Treatment Market Report (2022 to 2027) - Industry Trends, Share, Growth, Insight, Impact of COVID-19 and Company Analysis - ResearchAndMarkets.com

Retrieved on: 
星期二, 五月 10, 2022
Health, Pharmaceutical, Penicillin, Disorder, COVID-19, Urinary tract infection, Quinolone, US, Pregnancy, Insight, Prevalence, Patient, Infection, Complicated, Time-invariant system, Diagnosis, Diabetes, Knowledge, Government, Azole, MEA, Global, CAGR, UTI, Bacteria, Urethra, Research, Medical imaging, Antibiotics, Aminoglycoside, Growth

The "Urinary Tract Infection Treatment Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Urinary Tract Infection Treatment Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • A urinary tract infection (UTI) affects the urethra, bladder, ureters, and kidneys, with most disorders affecting the lower urinary tract.
  • The increased prevalence of urinary tract infections and the rise in the number of hospital visits for urinary tract infection testing and treatment predict that the urinary tract infection treatment market will grow significantly.
  • However, developing regions such as Asia-Pacific and the Middle East and Africa (MEA) are growing the urinary tract infection treatment market due to rising government initiatives for healthcare spending and increased knowledge about urinary tract infection treatment.

Global Antibacterial Market Research by Route of Administration, Drug Class, Distribution Channel, Geography, Competitive Analysis - Analysis & Forecasts 2021-2026 - ResearchAndMarkets.com

Retrieved on: 
星期五, 八月 20, 2021
Health, Pharmaceutical, CAGR, Genetically modified bacteria, Quinolone, Growth, Geography, Administration, Incidence, Skin, Infection, Route of administration, Bacteria, Climate change and infectious diseases, MDR, Pharmacy, NMPA, Public health, Macrolide, Toxicity, Tablet, Market share, Tetracycline, USD, Vaccine, Pharmaceutical industry

The global antibacterial market is being driven by factors such as increased cases of bacterial infections, changing climatical condition that causes bacterial infection, growing number aged population, and rising demand for efficient and affordable antibacterial Drugs.

Key Points: 
  • The global antibacterial market is being driven by factors such as increased cases of bacterial infections, changing climatical condition that causes bacterial infection, growing number aged population, and rising demand for efficient and affordable antibacterial Drugs.
  • Amongst the two, the enteral segment is estimated to hold the highest market share during the forecast period.
  • By Drug Class, the market is classified as B lactams, quinolones, macrolides, tetracycline, aminoglycoside, sulfonamide, phenicols, others.
  • Kyorin Pharmaceutical Receives Marketing Approval for Oral Quinolone Antibacterial Agent "Lasvic Tablets 75mg" - 20th September 2019.